Tag: NIV

These actions are in accordance with the Memorandum of Understanding (MoU) signed between ICMR-NIV Pune and BBIL for joint development of COVID-19 vaccine in April 2020

This forthcoming North Zone NIV Unit is poised to feature state-of-the-art biosafety level 2 and 3 laboratories, facilitating diagnostic testing support, surveillance, and research

The total funding of USD 122,475,000 will, over a period of five years, be distributed to the three top Indian health research institutions, Indian Council of Medical Research and its affiliated institutes, National Institute of Virology and National Institute of Epidemiology

Clinical specimens to be sent to NIV Pune Apex Laboratory through Integrated Disease Surveillance Programme (IDSP) network

Covid-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes Covid-19......................

Union Ministry of Health and Family Welfare rushes a multi-disciplinary team to assist Lakshadweep Administration in COVID-19 management.......................

As part of this collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA...............

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

In a major breakthrough, Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune has developed and validated the indigenous IgG ELISA test for antibody detection for COVID-19. ICMR has also partnered with Zydus Cadila for mass-scale production of the ELISA test kits...................

Complete CDV genome recovered by the scientists of ICMR-NIV for the first time in India. The scientists have also recommended existing CDV vaccine which should work as a protective intervention for Gir lions...………..